The Chemours (NYSE:CC) Announces Quarterly Earnings Results

Share on StockTwits

The Chemours (NYSE:CC) announced its quarterly earnings results on Sunday. The specialty chemicals company reported $0.71 EPS for the quarter, topping the consensus estimate of $0.63 by $0.08, MarketWatch Earnings reports. The business had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.40 billion. The Chemours had a negative net margin of 2.35% and a positive return on equity of 46.27%. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.71 EPS.

Shares of NYSE CC opened at $31.01 on Tuesday. The company has a debt-to-equity ratio of 5.54, a current ratio of 1.99 and a quick ratio of 1.23. The company has a market cap of $5.12 billion, a P/E ratio of -43.07 and a beta of 2.30. The Chemours has a 1 year low of $10.29 and a 1 year high of $32.21. The firm has a 50-day simple moving average of $28.53 and a two-hundred day simple moving average of $26.06.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 15th. Shareholders of record on Monday, May 17th will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 3.22%. The ex-dividend date is Friday, May 14th. The Chemours’s payout ratio is currently 39.84%.

Several brokerages have commented on CC. Royal Bank of Canada upgraded shares of The Chemours from a “sector perform” rating to an “outperform” rating and boosted their price target for the stock from $27.00 to $35.00 in a research note on Friday, January 8th. Citigroup boosted their price target on shares of The Chemours from $27.00 to $29.00 in a research note on Wednesday, February 17th. BMO Capital Markets boosted their price target on shares of The Chemours from $33.00 to $38.00 in a research note on Tuesday, February 16th. Finally, Morgan Stanley boosted their price target on shares of The Chemours from $28.00 to $30.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 16th. Six equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $26.67.

About The Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications.

Read More: What is the definition of arbitrage?

Earnings History for The Chemours (NYSE:CC)

Receive News & Ratings for The Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Chemours and related companies with's FREE daily email newsletter.